Medicare billing address
CMS Medicare provider billing file
15 Meade StSuite U-1
Wellsboro, PA 16901
CMS public data · NPI 1750392775
CMS public files list billing, prescribing, location, and participation fields for this NPI. Current plan networks, appointment availability, clinical outcomes, and patient-specific medical advice require separate verification.
CMS display name
Scott P Rutkoski, O.D.
Specialty
Credential
O.D.
NPI
1750392775
Primary source state
PA
Data retrieval date
July 28, 2026
Where these numbers come from, and what they cannot tell you
Public CMS records, 2024 reporting year. These are historical Medicare fields, not proof of current coverage, appointment availability, quality, or what someone will pay.
This page shows Medicare billing and Part D prescribing data for Scott P Rutkoski, O.D. from CMS public files. It covers 2024 claims data: services billed, the beneficiary panel, and the most-prescribed Part D drugs. It does not show current coverage, appointment availability, or quality ratings.
A licensed agent, not a call center
Peter Abilla, Licensed Medicare Insurance Sales Agent, NPN 22265186. Bring the doctors and prescriptions that matter to you, then check the details before you enroll.
Medicare participating
Yes
Individual assignment
Yes
Group assignment
Yes
CMS opt-out records
0
When CMS files list more than one address for the same NPI, each address stays tied to the CMS file that reported it.
CMS Medicare provider billing file
15 Meade StCMS Doctors & Clinicians file
15 Meade StIn the 2024 CMS provider billing file, this NPI had 1,616 Medicare beneficiaries and 6,874 total services. The average beneficiary age was 75, and the average HCC risk score was 0.9.
Total Medicare allowed amount
$458,551.17
Total Medicare payment amount
$286,854.35
Medicare beneficiaries
1,616
Total services
6,874
These percentages describe the Medicare beneficiary panel in the CMS utilization file. They are not a diagnosis for any individual patient and are not a quality score.
Hyperlipidemia
68%
CMS beneficiary-panel share
Hypertension
68%
CMS beneficiary-panel share
Diabetes
29%
CMS beneficiary-panel share
Ischemic heart disease
20%
CMS beneficiary-panel share
Chronic kidney disease
19%
CMS beneficiary-panel share
Osteoporosis
17%
CMS beneficiary-panel share
Where these service numbers come from, and what they cannot tell you
Amounts shown are average Medicare-approved amounts per billed unit in CMS records. What a person pays depends on current coverage and cannot be read from this table alone.
| CMS service description | Services | Avg allowed |
|---|---|---|
| Imaging of retina | 1,958 | $36.51 |
| Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 1,734 | $121.43 |
| Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | 910 | $85.63 |
| Exam of visual field with extended testing | 854 | $58.09 |
| Measurement of corneal pressure | 398 | $10.69 |
| Ultrasound scan of cornea to determine thickness | 340 | $10.02 |
| Evaluation of eye adaptation to light and dark with interpretation and report | 141 | $33.60 |
| Imaging of optic nerve | 102 | $33.02 |
| New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more | 92 | $158.85 |
| Photography of the retina | 85 | $34.19 |
Where these Part D numbers come from, and what they cannot tell you
CMS data reports historical prescription drug events attributed to NPI 1750392775. Formularies, copays, prior authorization, and step therapy rules vary by current coverage.
| Rank | Drug | Generic name | Total claims | 30-day fills | Total drug cost |
|---|---|---|---|---|---|
| 1 | Lumigan | Bimatoprost | 552 | 1,062 | $276,173.90 |
| 2 | Latanoprost | Latanoprost | 517 | 1,142.5 | $7,777.36 |
| 3 | Timolol Maleate | Timolol Maleate | 407 | 892.2 | $7,704.58 |
| 4 | Brimonidine Tartrate | Brimonidine Tartrate | 201 | 371 | $8,090.57 |
| 5 | Prednisolone Acetate | Prednisolone Acetate | 182 | 251.8 | $7,139.14 |
| 6 | Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 142 | 308.7 | $3,094.63 |
| 7 | Rhopressa | Netarsudil Mesylate | 114 | 170 | $51,944.37 |
| 8 | Dorzolamide Hcl | Dorzolamide Hcl | 111 | 249.8 | $1,832.70 |
| 9 | Simbrinza | Brinzolamide/Brimonidine Tart | 107 | 207 | $32,140.92 |
| 10 | Neomycin-Polymyxin-Dexameth | Neomycin/Polymyxin B/Dexametha | 99 | 99.7 | $1,217.56 |
CMS Part D records are historical aggregate claims data. They do not include current formulary status, pharmacy price, prior-authorization rules, network-directory status, or clinical-outcome data.
Medical school
Pennsylvania College Of Optometry
Graduation year
1995
Group/practice field
Grady D. Gafford Md Pc
Telehealth reported
Not reported
Verify plan-directory status, drug formulary rules, pharmacy pricing, appointment availability, and clinical questions against current plan documents and the relevant provider or care team.
The numbers above come from CMS public-use files for this NPI. Each link identifies the CMS release used and the retrieval date.